<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>RSNA 2018: Perspectum Diagnostics</title>
<link>https://rsna.vporoom.com/PerspectumDiagnostics/</link>
<description></description>
<item>
<title>Perspectum Diagnostics Showcases Quantitative MR-Based Biomarkers for Liver and Hepatobiliary Health at RSNA</title>
<link>https://rsna.vporoom.com/PerspectumDiagnostics/Perspectum-Diagnostics-Showcases-Quantitative-MR-Based-Biomarkers-for-Liver-and-Hepatobiliary-Health-at-RSNA</link>
<description>QIRR(011) reading room features the technology behind LiverMultiScan: multiparametric MRI</description>
<pubDate>Sun, 25 Nov 2018 10:00:00 -0500</pubDate>
<guid>https://rsna.vporoom.com/PerspectumDiagnostics/Perspectum-Diagnostics-Showcases-Quantitative-MR-Based-Biomarkers-for-Liver-and-Hepatobiliary-Health-at-RSNA</guid>
</item>
<item>
<title>Data released at The Liver Meeting® 2018 Shows MRCP+ is a Promising Non-Invasive Technology for Quantitative Evaluation of Hepatobiliary Diseases</title>
<link>https://rsna.vporoom.com/PerspectumDiagnostics/Data-released-at-The-Liver-Meeting-R-2018-Shows-MRCP-is-a-Promising-Non-Invasive-Technology-for-Quantitative-Evaluation-of-Hepatobiliary-Diseases</link>
<description>Two Abstracts Featuring Perspectum Diagnostics’ MRCP+ Accepted for Presentation at The Liver Meeting® 2018</description>
<pubDate>Mon, 12 Nov 2018 09:50:00 -0500</pubDate>
<guid>https://rsna.vporoom.com/PerspectumDiagnostics/Data-released-at-The-Liver-Meeting-R-2018-Shows-MRCP-is-a-Promising-Non-Invasive-Technology-for-Quantitative-Evaluation-of-Hepatobiliary-Diseases</guid>
</item>
<item>
<title>Predicting Clinical Outcomes with Multiparametric MRI Featuring Liver cT1 Equal to Biopsy, According to Research Presented at The Liver Meeting® 2018 </title>
<link>https://rsna.vporoom.com/PerspectumDiagnostics/Predicting-Clinical-Outcomes-with-Multiparametric-MRI-Featuring-Liver-cT1-Equal-to-Biopsy-According-to-Research-Presented-at-The-Liver-Meeting-R-2018</link>
<description>Two Abstracts Featuring Perspectum Diagnostics’ LiverMultiScan Selected as Posters of Distinction</description>
<pubDate>Fri, 09 Nov 2018 09:49:00 -0500</pubDate>
<guid>https://rsna.vporoom.com/PerspectumDiagnostics/Predicting-Clinical-Outcomes-with-Multiparametric-MRI-Featuring-Liver-cT1-Equal-to-Biopsy-According-to-Research-Presented-at-The-Liver-Meeting-R-2018</guid>
</item>
<item>
<title>FDA Clearance For Perspectum Diagnostics’ LiverMultiScan™ Means More Patients Can Benefit From Access To State-Of-The-Art Non-Invasive Diagnostic Aid For Liver Disorders</title>
<link>https://rsna.vporoom.com/PerspectumDiagnostics/index.php?s=35889&amp;item=122742</link>
<description>- More patients can benefit from non-invasive assessment of the liver through expanded compatibility with MRI systems 
</description>
<pubDate>Mon, 27 Nov 2017 04:00:00 -0500</pubDate>
<guid>https://rsna.vporoom.com/PerspectumDiagnostics/index.php?s=35889&amp;item=122742</guid>
</item>
</channel>
</rss>
